- This event has passed.
Mitochondria-Targeted Drug Development Summit
22 February, 2022 - 24 February, 2022
Abliva will attend and present at the Mitochondria-Targeted Drug Development Summit in Boston, MA, USA. The event will be held on 22 – 24 February 2022.
CEO Ellen Donnelly will be presenting in the session Patient-Focused Drug Development for Mitochondrial Disease.
Synopsis:
- Highlighting the impact of patient input on research and development at Abliva
- Providing an overview of the multiple therapeutic options for mitochondrial disease being pursued at Abliva
- Presenting placebo controlled PMD patient data from our lead asset, KL1333